Literature DB >> 18507017

Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany.

Thomas Wex1, Matthias P A Ebert, Siegfried Kropf, Jutta Dierkes, Katrin Schüttler, Christoph Röcken, Michael Höcker, Peter Malfertheiner.   

Abstract

BACKGROUND: NOD-2 is involved in the intracellular recognition of bacterial muramyl dipeptides, and three independent polymorphisms of this gene have been identified as risk factors for the development of Crohn's disease. PATIENTS AND METHODS: To study the role of NOD-2 in gastric carcinogenesis, NOD-2 mutations (SNP5: P268S, SNP8: R702W, SNP12: G908R, and SNP13: 3020insC) were genotyped in 171 patients with gastric cancer and 153 controls.
RESULTS: Applying a numerical model, SNP5 was found to carry a slightly increased risk (OR = 2.25, 95% CI: 1.05-2.17, p = 0.027) for the development of gastric cancer, whereas SNP8 was similarly distributed between controls and patients with gastric cancer. SNP5 and 8 were found to be genetically linked in both groups (p < 0.02). The allele frequency of SNP12 and 13 were rare and therefore analyzed in subgroups only and not statistically analyzed due to the lack of statistical power.
CONCLUSION: NOD-2 is not a risk factor for gastric carcinogenesis in the Caucasian population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507017

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Gastric carcinogenesis.

Authors:  Jan Bornschein; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2011-05-25       Impact factor: 3.445

Review 2.  Pathogen recognition receptors, cancer and inflammation in the gut.

Authors:  Masayuki Fukata; Maria T Abreu
Journal:  Curr Opin Pharmacol       Date:  2009-10-12       Impact factor: 5.547

3.  Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians.

Authors:  Juozas Kupcinskas; Thomas Wex; Jan Bornschein; Michael Selgrad; Marcis Leja; Elona Juozaityte; Gediminas Kiudelis; Laimas Jonaitis; Peter Malfertheiner
Journal:  BMC Med Genet       Date:  2011-08-24       Impact factor: 2.103

4.  Eradication Treatment of Helicobacter pylori Infection: Its Importance and Possible Relationship in Preventing the Development of Gastric Cancer.

Authors:  Bruna Maria Roesler; Sandra Cecília Botelho Costa; José Murilo Robilotta Zeitune
Journal:  ISRN Gastroenterol       Date:  2012-06-13

5.  NOD1 and NOD2 Genetic Variants in Association with Risk of Gastric Cancer and Its Precursors in a Chinese Population.

Authors:  Zhe-Xuan Li; Yu-Mei Wang; Fu-Bing Tang; Lian Zhang; Yang Zhang; Jun-Ling Ma; Tong Zhou; Wei-Cheng You; Kai-Feng Pan
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

6.  NOD2 maybe a biomarker for the survival of kidney cancer patients.

Authors:  Deguo Xu; Shuisheng Zhang; Shenfeng Zhang; Hongmei Liu; Paiyun Li; Lili Yu; Heli Shang; Yong Hou; Yuan Tian
Journal:  Oncotarget       Date:  2017-10-06

7.  NOD2 Arg702Trp Polymorphism in Romanian Patients with Gastric Cancer.

Authors:  D N Florescu; D R Tudoraşcu; F Burada; M G Cucu; M E Ciurea
Journal:  Curr Health Sci J       Date:  2015-12-22

8.  NOD2 polymorphisms associated with cancer risk: a meta-analysis.

Authors:  Jingwei Liu; Caiyun He; Qian Xu; Chengzhong Xing; Yuan Yuan
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 9.  Pattern-recognition receptors and gastric cancer.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.